Reglődi D - Search Results

1

Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons.

Sághy É, Payrits M, Helyes Z, Reglődi D, Bánki E, Tóth G, Couvineau A, Szőke É. Sághy É, et al. Among authors: reglodi d. Neuroscience. 2015 Nov 12;308:144-56. doi: 10.1016/j.neuroscience.2015.08.043. Epub 2015 Aug 28. Neuroscience. 2015. PMID: 26321242

2

Pituitary adenylate cyclase activating polypeptide is highly abundant in the nervous system of anoxia-tolerant turtle, Pseudemys scripta elegans.

Reglödi D, Somogyvári-Vigh A, Vígh J, Li M, Lengvári I, Arimura A. Reglödi D, et al. Peptides. 2001 Jun;22(6):873-8. doi: 10.1016/s0196-9781(01)00412-0. Peptides. 2001. PMID: 11390016

3

Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.

Reglodi D, Lubics A, Tamás A, Szalontay L, Lengvári I. Reglodi D, et al. Behav Brain Res. 2004 May 5;151(1-2):303-12. doi: 10.1016/j.bbr.2003.09.007. Behav Brain Res. 2004. PMID: 15084446

4

Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury.

Farkas O, Tamás A, Zsombok A, Reglodi D, Pál J, Büki A, Lengvári I, Povlishock JT, Dóczi T. Farkas O, et al. Among authors: reglodi d. Regul Pept. 2004 Dec 15;123(1-3):69-75. doi: 10.1016/j.regpep.2004.05.014. Regul Pept. 2004. PMID: 15518895

5

Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodium-glutamate.

Tamás A, Gábriel R, Rácz B, Dénes V, Kiss P, Lubics A, Lengvári I, Reglodi D. Tamás A, et al. Among authors: reglodi d. Neurosci Lett. 2004 Nov 30;372(1-2):110-3. doi: 10.1016/j.neulet.2004.09.021. Neurosci Lett. 2004. PMID: 15531098

6

Pituitary adenylate cyclase activating polypeptide plays a role in olfactory memory formation in chicken.

Józsa R, Hollósy T, Tamás A, Tóth G, Lengvári I, Reglodi D. Józsa R, et al. Among authors: reglodi d. Peptides. 2005 Nov;26(11):2344-50. doi: 10.1016/j.peptides.2005.03.054. Epub 2005 May 31. Peptides. 2005. PMID: 15927304

7

Pituitary adenylate cyclase activating polypeptide protects cardiomyocytes against oxidative stress-induced apoptosis.

Gasz B, Rácz B, Roth E, Borsiczky B, Ferencz A, Tamás A, Cserepes B, Lubics A, Gallyas F Jr, Tóth G, Lengvári I, Reglodi D. Gasz B, et al. Among authors: reglodi d. Peptides. 2006 Jan;27(1):87-94. doi: 10.1016/j.peptides.2005.06.022. Epub 2005 Aug 10. Peptides. 2006. PMID: 16095757

8

Degree of damage compensation by various PACAP treatments in monosodium glutamate-induced retinal degeneration.

Babai N, Atlasz T, Tamás A, Reglödi D, Tóth G, Kiss P, Gábriel R. Babai N, et al. Among authors: reglodi d. Neurotox Res. 2005 Nov;8(3-4):227-33. doi: 10.1007/BF03033976. Neurotox Res. 2005. PMID: 16371317

9

Postinjury administration of pituitary adenylate cyclase activating polypeptide (PACAP) attenuates traumatically induced axonal injury in rats.

Tamás A, Zsombok A, Farkas O, Reglödi D, Pál J, Büki A, Lengvári I, Povlishock JT, Dóczi T. Tamás A, et al. Among authors: reglodi d. J Neurotrauma. 2006 May;23(5):686-95. doi: 10.1089/neu.2006.23.686. J Neurotrauma. 2006. PMID: 16689670

10

Search for the optimal monosodium glutamate treatment schedule to study the neuroprotective effects of PACAP in the retina.

Babai N, Atlasz T, Tamás A, Reglodi D, Tóth G, Kiss P, Gábriel R. Babai N, et al. Among authors: reglodi d. Ann N Y Acad Sci. 2006 Jul;1070:149-55. doi: 10.1196/annals.1317.003. Ann N Y Acad Sci. 2006. PMID: 16888157

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters